Literature DB >> 21847074

Avian influenza surveillance with FTA cards: field methods, biosafety, and transportation issues solved.

Robert H S Kraus1, Pim van Hooft, Jonas Waldenström, Neus Latorre-Margalef, Ronald C Ydenberg, Herbert H T Prins.   

Abstract

Avian Influenza Viruses (AIVs) infect many mammals, including humans(1). These AIVs are diverse in their natural hosts, harboring almost all possible viral subtypes(2). Human pandemics of flu originally stem from AIVs(3). Many fatal human cases during the H5N1 outbreaks in recent years were reported. Lately, a new AIV related strain swept through the human population, causing the 'swine flu epidemic'(4). Although human trading and transportation activity seems to be responsible for the spread of highly pathogenic strains(5), dispersal can also partly be attributed to wild birds(6, 7). However, the actual reservoir of all AIV strains is wild birds. In reaction to this and in face of severe commercial losses in the poultry industry, large surveillance programs have been implemented globally to collect information on the ecology of AIVs, and to install early warning systems to detect certain highly pathogenic strains(8-12). Traditional virological methods require viruses to be intact and cultivated before analysis. This necessitates strict cold chains with deep freezers and heavy biosafety procedures to be in place during transport. Long-term surveillance is therefore usually restricted to a few field stations close to well equipped laboratories. Remote areas cannot be sampled unless logistically cumbersome procedures are implemented. These problems have been recognised(13, 14) and the use of alternative storage and transport strategies investigated (alcohols or guanidine)(15-17). Recently, Kraus et al.(18) introduced a method to collect, store and transport AIV samples, based on a special filter paper. FTA cards(19) preserve RNA on a dry storage basis(20) and render pathogens inactive upon contact(21). This study showed that FTA cards can be used to detect AIV RNA in reverse-transcription PCR and that the resulting cDNA could be sequenced and virus genes and determined. In the study of Kraus et al.(18) a laboratory isolate of AIV was used, and samples were handled individually. In the extension presented here, faecal samples from wild birds from the duck trap at the Ottenby Bird Observatory (SE Sweden) were tested directly to illustrate the usefulness of the methods under field conditions. Catching of ducks and sample collection by cloacal swabs is demonstrated. The current protocol includes up-scaling of the work flow from single tube handling to a 96-well design. Although less sensitive than the traditional methods, the method of FTA cards provides an excellent supplement to large surveillance schemes. It allows collection and analysis of samples from anywhere in the world, without the need to maintaining a cool chain or safety regulations with respect to shipping of hazardous reagents, such as alcohol or guanidine.

Entities:  

Mesh:

Year:  2011        PMID: 21847074      PMCID: PMC3211123          DOI: 10.3791/2832

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


Trap dabbling ducks of the genus Anas (or other birds) in a cage by attracting them with lure ducks or food, and put them into individual card board boxes. Transportation time in the box should be kept to a minimum, for instance, by installing a field station within a short distance to the trap. Logistic circumstances may vary in each study. The advice and approval of the relevant animal ethics committee needs to be sought for each new set-up. Alternatively, also hunter shot birds can be sampled. Take the duck out of the box by holding its wings tight to its body. Sample a fresh dropping, which will be present in most of the cases, directly from the bottom of the box. Pick them up with a sterile swab and apply the fluid to a Whatman FTA card. If not, perform cloacal swabbing. Turn the duck on its back. This permits access to the cloaca and facilitates sampling. The cloaca is a protruding structure situated below the abdomen, close to the base of the tail. An experienced person could hold and sample the bird at the same time, or else a second person can assist. Carefully insert the sterile plastic rayon swab (Copan, Italy) approximately 1 cm and make a gentle swirl of the cloaca. Roll the swab with the fluids from the cloaca over the surface of a Whatman FTA card. After sampling has been performed immediate release of the animal is desireable. Dry the FTA cards at room temperature for at least 1 hour, then store each sample individually in paper bags (e.g. envelopes). Storage is possible at room temperature, possibly with silica beads in humid climates. The sending and receiving institutions' biosafety officers can permit to send FTA cards by regular mail, since the pathogens become inactive upon contact with the FTA card surface. Extract the FTA card material including faeces/cloacal fluid. Punch three discs with a Harris 2 mm puncher and place all of those into a well of an RNase free 96well plate. Between each new sample, clean the puncher carefully with alcohol and a Kim precision wipe (Kimtech). Always use positive and negative controls. A positive control can consist of a laboratory strain freshly applied to an FTA card, or a natural sample which is know to yield a positive result. As negative control, punch out discs from an empty FTA card. Additionally, leave another well free for a PCR control later in your experiment (with water as template). Add 70μl RNA rapid extraction solution (Ambion) and heat-seal the plate (AbGene Thermo-Sealer). Incubate 5 minutes on a plate shaker at room temperature with the determined speed that does not cause spill-over (this depends on the used plate shaker model; test in advance). Carry viral RNA isolation according to the manufacturer's protocols with the MagMAX-96 viral RNA isolation kit (Ambion). In brief: Add 130μl prepared lysis/binding solution (from the kit) to each well. Transfer 50μl extracted FTA card material to each well. Shake plate for 1 minute. Add 20μl prepared bead mix (from the kit) to each sample and mix by pipetting up and down. Shake on determined speed for 5 minutes. RNA molecules will bind to the magnetic beads. Move the plate to a magnetic 96-well stand to capture the beads. Depending on the model of magnetic stand used, this can take more than 5 minutes. When the solution has turned completely clear, remove and discard the supernatant. Then remove the plate from the magnetic stand. Wash the beads twice with wash solution 1 and twice with wash solution 2 (from the kit). For each of the 4 wash steps add 150μl prepared wash solution to each sample, shake for 1 minute on determined speed, move the plate to the magnetic stand, capture beads for about 5 minutes (or until the solution is completely clear), remove and discard the supernatant. Then remove the plate from the magnetic stand, add the next wash solution, and carry out the washing steps as previously. After the last washing step, remove as much wash solution as possible and air dry the beads at room temperature in the plate shaker for 2 minutes. Add 50μl of elution buffer (from the kit) to release RNA from the beads and shake for 4 minutes on the plate shaker. Capture beads as previously described. The supernatant now contains the isolated RNA which is ready for downstream applications.

Protocol

3. RT-PCR of the AIV Matrix Gene

Carry out reverse transcription PCR (RT-PCR) with the One-Step Access RT-PCR system (Promega) in 25 μl reactions (adjusted from Kraus et al.18 and Fouchier et al.22): PCR conditions in a Biometra T1 thermocycler are: initial reverse transcription of 45 minutes at 45°C, followed by 2 minutes initial denaturation at 94°C and 40 cycles of: 94°C for 1 minute, 56°C for 1 minute, and 68°C for 2 minutes. An additional 7 minutes elongation at 68°C concludes the amplification. Load 2μl of the PCR product mixed with 2μl 5x loading dye (BioRad) and 6μl water on a 1% agarose gel (Roche) stained with 1% ethidium bromide (2.5μl per 100 ml gel) for a pre-screening. Run the gel for 1 hour at 120V, along with a DNA size standard (BioRad EZ load 100 bp ladder), visualise with a gel documentation system. See an example in Figure 1. Select samples with amplified fragments in the expected size range (between 200 bp and 300 bp (target fragment is 244 bp). Load the whole PCR reaction volume (of which ˜23μl are left) of these candidates with 6μl 5x loading dye on a 2% ethidium bromide stained agarose gel and run for 2 hours. Place the gel on a UV-transilluminator (Bioblock Scientific) and inspected visually. See an example in Figure 2. Excise bands of the correct size from gel with a scalpel and placed into individual 1.5 ml reaction tubes. Purify fragments from gel, for instance with the Zymoclean Gel DNA Recovery Kit (Zymo Research). Carry out Sanger sequencing of the target fragments, for instance on an ABI 3730 capillary sequencer with ABI Big Dye 3.1 chemistry (Applied Biosystems). Prepare sequencing reactions in 10μl volumes containing 10-20 ng gel-purified template cDNA, 1.75μl 5x dilution buffer, 0.5μl Big Dye V3.1 premix, 1 μl forward primer (M52C20, 10 mM), and ddH2O. Cycling conditions are: 1 min initial denaturation, followed by 25 cycles of: 10 s at 96°C, 5 s at 45°C and 4 min at 60°C. Purify and prepare the sequencing reaction according to your internal protocols. Identify resulting cDNA sequences against nucleotide databases such as GenBank23, e.g. by web based tools such as BLAST at the National Centre for Biotechnology Information (NCBI, http://blast.ncbi.nlm.nih.gov/Blast.cgi).

6. Representative Results:

Mallards (Anas platyrhynchos) were sampled at Ottenby Bird Observatory in December 2007. From each mallard a sample on FTA card was taken as described in this protocol. After shipping, the FTA cards were kept in a freezer at -20°C for two years. The same FTA card sample of the laboratory isolate tested in Kraus et al.18 was included as positive control, as well as nine tenfold serial dilutions of it. Two negative controls were i) extraction from an empty FTA card, to test if there was carry-over from the puncher, and ii) RT-PCR reaction in which nuclease free water was used as template, to test if contamination occurred during, or in preparation of the PCR reaction. 84 samples were analysed. A gel picture of the PCR products from these 84 samples can be found in Figure 1. From natural samples a multitude of unspecific bands can be observed due to the presence of various microbial contaminations in the faeces. However, the target fragment of the primer pair is 244 bp long. The whole PCR-reaction volume of a subset of the samples which produced fragments in approximately the correct size range (between 200 bp and 300 bp) was loaded on gel (Figure 1). An illustration of which of the bands were cut from the gel can be found in Supplementary Figure 1. In addition to the positive control, two of these samples (69899 and 69912) were positive by the new protocol. A BLAST search against the NCBI nucleotide database revealed their identity as AI matrix gene (Figure 3), while all the other bands resembled bacterial sequences most closely, or did not yield a readable sequence at all. Figure 1. Gel picture of a preliminary screening of the PCR products. 2 μl PCR product of positive control, serial dilutions of the positive control, two negative controls and 84 cloacal samples were loaded. 48 samples are shown in the top gel panel, and 48 samples in the bottom panel. Red arrows indicate gel lanes used for 100 bp DNA size standard. For illustration, red circles show bands in the expected size range. Blue circles indicate an unspecific amplicon (top left) or a primer dimer artefact below 100 bp in size (bottom right). Figure 2. Selection of samples with fragments in the correct size range. Samples with bands between 200 bp and 300 bp (target fragment 244 bp) were chosen. The green arrow indicates the positive control, the two red arrows indicate samples which were confirmed to be AIV positive by comparing their cDNA sequences to the NCBI nucleotide database. Figure 3. Screen capture of a representative BLAST search at NCBI. One of the cDNA sequences obtained from the excised fragments was queried against the nucleotide database at the NCBI website. The sample is correctly identified as AI Matrix gene fragment. To view a full sized version of this image, click here. Supplementary Figure S1. Bands of selected samples excised from gel. This picture was taken from the gel depicted in Figure 1 after candidate bands between 200 bp and 300 bp were cut out.

Discussion

The protocol described here provides a supplementary method to screen faecal or similar samples for the presence of AIV. It was especially designed to make sample collection quick and easy. This makes it possible for less trained persons, such as hunters or wildlife managers, to contribute to AI surveillance. No cool chains need to be applied, although freezing the samples is recommended where possible. A few days of room temperature, for instance during transport to the laboratory, were not a problem for RNA molecules on FTA cards, as long as the cards remained dry. Other non-cooled storage systems that are currently evaluated by the research community, such as alcohol15 or guanidine16, require special shipping arrangements because of their hazardous nature. In contrast, the FTA card method does not require shipping of hazardous materials. However, another interesting storage medium in this respect is RNAlater™ that is not hazardous, either17. Sample analysis can be carried out in any standard molecular laboratory. No special equipment other than for usual PCR reactions and capillary sequencing was needed. All steps could be carried out without a biosafety level because already at sample collection the potential pathogenic agents were inactivated by the antibacterial and antiviral activity of the FTA card. Cross-contamination and subsequent false positive samples were not observed in our trials with wild bird samples. However, when working with RNA and PCR it is always advisable to pay special attention to clean working places and separate rooms for pre- and post-PCR steps. Working in a fume hood decreases the risk of aerosol contamination in the laboratory. Pipetting needs to be carried out with filter tips. From a previous study on samples taken simultaneously from the same ducks we know that six of the 84 samples were positive by the traditional RealTime RT-PCR method24 and the Ct values from RealTime RT-PCR are known. The two positive samples detected by our method stem from ducks which had Ct values <30 (indicating a high concentration of viral RNA). The other four samples which were positive with the traditional protocol had Ct values >30 (less concentrated) and could not be detected by our protocol. Only samples with relatively high virus titers were positive in our assay and it is likely that sensitivity of the method was the source of failure to detect all positive samples. Further, the sample size in the current study was very low and the method can be completely developed and assessed if more controlled and rigorous experiments are carried out. However, if these samples would have been collected from a remote area, traditional analysis would not have been possible at all. Additionally, these first results stem from pilot experiments which need further optimisation. A period of two years storage in a regular -20°C freezer after sample collection probably also affected the quality of the viral RNA. This possible RNA degradation is an important issue when dealing with room temperature storage of inactivated viruses. Samples stored in alternative liquids as mentioned above suffer from significant degradation which impacts analysis of longer stretches of the viral genome16. Although not tested in our study, FTA cards have proven to be well suited to preserve intact RNA molecules in other RNA systems that are very similar to Avian Influenza viruses25, 26.

Disclosures

Trapping, handling and sampling of birds were done following national legislation and were approved by the Swedish Board of Agriculture and the research animal ethics committee.
Nuclease free water1.5μl
AMV/Tfl5 buffer5μl
dNTPs0.5μl
primer M52C22 (10 μM)2.5μl
primer M253R22 (10 μM)2.5μl
MgSO4 (25 mM)7μl
AMV reverse transcriptase (5u/μl)0.5μl
Tfl polymerase (5u/μl)0.5μl
RNA sample5μl
  22 in total

1.  Swine flu goes global.

Authors:  Declan Butler
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

2.  Spatio-temporal dynamics of global H5N1 outbreaks match bird migration patterns.

Authors:  Yali Si; Andrew K Skidmore; Tiejun Wang; Willem F de Boer; Pravesh Debba; Albert G Toxopeus; Lin Li; Herbert H T Prins
Journal:  Geospat Health       Date:  2009-11       Impact factor: 1.212

3.  Reverse transcription of an RNA genome from databasing paper (FTA(R)).

Authors:  C D Rogers; L A Burgoyne
Journal:  Biotechnol Appl Biochem       Date:  2000-06       Impact factor: 2.431

4.  Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene.

Authors:  R A Fouchier; T M Bestebroer; S Herfst; L Van Der Kemp; G F Rimmelzwaan; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

5.  The effect of sample type, temperature and RNAlater on the stability of avian influenza virus RNA.

Authors:  Julie L Forster; Valerie B Harkin; David A Graham; Samuel J McCullough
Journal:  J Virol Methods       Date:  2008-02-21       Impact factor: 2.014

6.  Evaluation of FTA cards as a laboratory and field sampling device for the detection of foot-and-mouth disease virus and serotyping by RT-PCR and real-time RT-PCR.

Authors:  Madhanmohan Muthukrishnan; Nagendrakumar B Singanallur; Kumar Ralla; Srinivasan A Villuppanoor
Journal:  J Virol Methods       Date:  2008-06-26       Impact factor: 2.014

7.  Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests.

Authors:  Vincent J Munster; Chantal Baas; Pascal Lexmond; Theo M Bestebroer; Judith Guldemeester; Walter E P Beyer; Emmie de Wit; Martin Schutten; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

8.  Effects of influenza A virus infection on migrating mallard ducks.

Authors:  Neus Latorre-Margalef; Gunnar Gunnarsson; Vincent J Munster; Ron A M Fouchier; Albert D M E Osterhaus; Johan Elmberg; Björn Olsen; Anders Wallensten; Paul D Haemig; Thord Fransson; Lars Brudin; Jonas Waldenström
Journal:  Proc Biol Sci       Date:  2009-03-22       Impact factor: 5.349

9.  GenBank.

Authors:  Dennis A Benson; Ilene Karsch-Mizrachi; David J Lipman; James Ostell; Eric W Sayers
Journal:  Nucleic Acids Res       Date:  2009-11-12       Impact factor: 16.971

10.  Wild bird influenza survey, Canada, 2005.

Authors:  E Jane Parmley; Nathalie Bastien; Timothy F Booth; Victoria Bowes; Peter A Buck; Andre Breault; Dale Caswell; Pierre-Yves Daoust; J Chris Davies; Seyyed Mehdy Elahi; Madeleine Fortin; Fred Kibenge; Robin King; Yan Li; Norman North; Davor Ojkic; John Pasick; Sydney Paul Pryor; John Robinson; Jean Rodrigue; Hugh Whitney; Patrick Zimmer; Frederick A Leighton
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more
  20 in total

1.  Evaluation of the FTA carrier device for human papillomavirus testing in developing countries.

Authors:  Paula Gonzalez; Bernal Cortes; Wim Quint; Aimée R Kreimer; Carolina Porras; Ana Cecilia Rodríguez; Silvia Jimenez; Rolando Herrero; Linda Struijk; Allan Hildesheim; Willem Melchers
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

2.  How Does Sampling Methodology Influence Molecular Detection and Isolation Success in Influenza A Virus Field Studies?

Authors:  Neus Latorre-Margalef; Alexis Avril; Conny Tolf; Björn Olsen; Jonas Waldenström
Journal:  Appl Environ Microbiol       Date:  2015-12-11       Impact factor: 4.792

3.  Long-term variation in influenza A virus prevalence and subtype diversity in migratory mallards in northern Europe.

Authors:  Neus Latorre-Margalef; Conny Tolf; Vladimir Grosbois; Alexis Avril; Daniel Bengtsson; Michelle Wille; Albert D M E Osterhaus; Ron A M Fouchier; Björn Olsen; Jonas Waldenström
Journal:  Proc Biol Sci       Date:  2014-02-26       Impact factor: 5.349

4.  Novel approach for deriving genome wide SNP analysis data from archived blood spots.

Authors:  Katie E Fowler; Chris P Reitter; Grant A Walling; Darren K Griffin
Journal:  BMC Res Notes       Date:  2012-09-13

5.  Pan-African genetic structure in the African buffalo (Syncerus caffer): investigating intraspecific divergence.

Authors:  Nathalie Smitz; Cécile Berthouly; Daniel Cornélis; Rasmus Heller; Pim Van Hooft; Philippe Chardonnet; Alexandre Caron; Herbert Prins; Bettine Jansen van Vuuren; Hans De Iongh; Johan Michaux
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

6.  Flexibility of continental navigation and migration in European mallards.

Authors:  Mariëlle L van Toor; Anders Hedenström; Jonas Waldenström; Wolfgang Fiedler; Richard A Holland; Kasper Thorup; Martin Wikelski
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

7.  Prevalence of avian paramyxovirus type 1 in Mallards during autumn migration in the western Baltic Sea region.

Authors:  Conny Tolf; Michelle Wille; Ann-Katrin Haidar; Alexis Avril; Siamak Zohari; Jonas Waldenström
Journal:  Virol J       Date:  2013-09-12       Impact factor: 4.099

8.  Xenosurveillance: a novel mosquito-based approach for examining the human-pathogen landscape.

Authors:  Nathan D Grubaugh; Supriya Sharma; Benjamin J Krajacich; Lawrence S Fakoli; Fatorma K Bolay; Joe W Diclaro; W Evan Johnson; Gregory D Ebel; Brian D Foy; Doug E Brackney
Journal:  PLoS Negl Trop Dis       Date:  2015-03-16

9.  Assessment of the RNASound RNA Sampling Card for the Preservation of Influenza Virus RNA.

Authors:  Hilda Lau; Aeron C Hurt
Journal:  Front Microbiol       Date:  2016-11-02       Impact factor: 5.640

10.  Heterosubtypic immunity to influenza A virus infections in mallards may explain existence of multiple virus subtypes.

Authors:  Neus Latorre-Margalef; Vladimir Grosbois; John Wahlgren; Vincent J Munster; Conny Tolf; Ron A M Fouchier; Albert D M E Osterhaus; Björn Olsen; Jonas Waldenström
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.